07:00 , Apr 10, 2000 |  BC Week In Review  |  Company News

AccuMed, BCAM International Inc. deal

BCAM obtained exclusive rights to use ACMI's cellular image analysis technology in the field of morphological, cytochemical, cytogenic and quantitative sputum cytology for early lung cancer detection, screening or therapeutic monitoring. AccuMed International Inc. (ACMI),...
07:00 , Aug 23, 1999 |  BC Week In Review  |  Company News

AccuMed board of directors update

AccuMed International Inc. (ACMI), Chicago, Ill.   Business: Diagnostics/Imaging   Resigned: Harold Blue  ...
07:00 , Apr 19, 1999 |  BC Week In Review  |  Clinical News

AccuMed regulatory update

ACMI received U.S. Patent No. 5,889,881 covering the automatic detection of malignancy-associated changes. The technology is part of ACMI's AcCell-Savant image cytometry products. AccuMed International Inc. (ACMI), Chicago, Ill.   Business: Diagnostics/Imaging  ...
07:00 , Apr 5, 1999 |  BC Week In Review  |  Company News

AccuMed management update

AccuMed International Inc. (ACMI), Chicago, Ill.   Business: Diagnostics/Imaging   Promoted: Norman Pressman to president from SVP of R&D while remaining CSO  ...
08:00 , Mar 15, 1999 |  BC Week In Review  |  Company News

AccuMed, Bell National Corp. deal

The companies signed a letter of intent for Bell to acquire rights to ACMI's AcCell 2000, 2001 and 3000 computer-aided microscopy workstations, including inventory and responsibility for ACMI's existing AcCell installations and contracts. ACMI, which...
08:00 , Feb 8, 1999 |  BC Week In Review  |  Company News

AccuMed, Key Equity Capital Corp. deal

ACMI completed the sale of its microbiology business for $15.3 million in cash to Trek Diagnostic Systems , a new entity formed by Key Equity Capital and Michael Burke, a former ACMI executive (see BioCentury,...
08:00 , Jan 4, 1999 |  BC Week In Review  |  Company News

AccuMed, Key Equity Capital Corp. deal

ACMI stock and noteholders approved the sale of the company's microbiology business to AMI Acquisition Corp., a joint venture between Key Equity and former ACMI employee Michael Burke (see BioCentury, Dec. 7). AccuMed International Inc....
08:00 , Dec 7, 1998 |  BC Week In Review  |  Company News

AccuMed, Key Equity Capital Corp. deal

ACMI signed a definitive agreement to sell its microbiology business for $15.8 million in cash to AMI Acquisition Corp., a new entity formed by Key Equity Capital and Michael Burke, a former ACMI executive (see...
07:00 , Jul 6, 1998 |  BC Week In Review  |  Company News

AccuMed, Xillix deal

ACMIC acquired the 1 million shares of Oncometrics Imaging Corp. (Vancouver, B.C.) it did not own as a result of its purchase from Xillix (see BioCentury, June 1). Oncometrics becomes a wholly-owned subsidiary of ACMIC....
07:00 , Jun 22, 1998 |  BC Week In Review  |  Company News

AccuMed, KeyCorp deal

In an effort to focus on its cytology business, ACMCD signed a letter of intent to sell its microbiology business to KeyCorp's Key Equity Capital Corp. affiliate and a former executive of the microbiology business....